MedTrace Logo

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

NCT00897338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2015-10-12

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and pleural or peritoneal fluid from patients with metastatic breast cancer in the laboratory may help doctors identify biomarkers related to breast cancer and learn more about how breast cancer begins and spreads in the body.

PURPOSE: This research study is looking at a new way of identifying circulating breast cancer cells in blood and in pleural or peritoneal fluid in women with metastatic breast cancer.

Conditions

Interventions

OTHER

flow cytometry

laboratory analysis

OTHER

fluorescence activated cell sorting

laboratory analysis

OTHER

immunohistochemistry staining method

laboratory analysis

OTHER

immunologic technique

laboratory analysis

OTHER

biomarker analysis

laboratory analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Vered Stearns, MD · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897338 on ClinicalTrials.gov